category,datetime,headline,id,image,related,source,summary,url
company,1769185621,"Kenvue Set for 'Muted' Q4 Amid Difficult Environment, Tylenol Pressure, RBC Says",138227156,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,KVUE,Yahoo,"Kenvue (KVUE) is set to report a ""muted"" Q4, as the environment remains difficult and the company de",https://finnhub.io/api/news?id=ab9a5166ba56d47ffafa3a3df85d3d234a348af00fb1c795f50f2b3da76cd964
company,1769184267,"Kimberly-Clark's Quarterly Results to Largely Match Expectations, RBC Says",138227157,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,KVUE,Yahoo,Kimberly-Clark (KMB) is poised to report fourth-quarter results largely in line with recently reduce,https://finnhub.io/api/news?id=3b6e363ec494c5d5fd951c5a01b212b16aaf0657ac6ab216f6deed20d1c0e520
company,1769159642,Assessing Kenvue (KVUE) After Its Separation From Johnson & Johnson,138222881,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,KVUE,Yahoo,"If you are wondering whether Kenvue is priced attractively right now, this article will walk you through what the current share price may be implying about its value. Kenvue's stock recently closed at US$17.75, with returns of 2.8% over 7 days, 4.3% over 30 days, 2.5% year to date, and a 10.9% decline over the past year. These moves can signal changing views on both its potential and its risks. Recent headlines have focused on Kenvue as an independent consumer health company following its...",https://finnhub.io/api/news?id=af902ae480fa1f1218d732ec6b44e3f8e7b5466be0bf8a5c27a00cb4c28f5169
company,1769158407,Jim Cramer's top 10 things to watch in the stock market Friday,138226380,https://image.cnbcfm.com/api/v1/image/108254809-1768998267409-gettyimages-2256812762-AFP_93GN3UY.jpeg?v=1768998291&w=1920&h=1080,KVUE,CNBC,Stocks pointed to a lower open after the major U.S. averages posted back-to-back gains.,https://finnhub.io/api/news?id=d64346149825a6a02b769e0806916738a3f9f90077d78babeb5a69e7b656ca14
